Skip to main content
. 2014 Oct 15;16(5):458. doi: 10.1186/s13075-014-0458-4

Figure 2.

Figure 2

Flow diagram of the study. Displays the study flow: 49 patients were screened, 26 corresponded to the inclusion and exclusion criteria and signed the study informed consent form, 21 (81%) finished the first treatment period and 20 (95%) the second treatment period. Overall, 25 patients completed the methotrexate (MTX) treatment period and 21 the placebo (PBO) treatment period.